Key Findings
The United States precision medicine market is expected to record a CAGR of 9.76%, during the forecast years. The initiatives introduced by the government and the surging demand for precision medicine are anticipated to supplement the country’s market growth. While the base year considered for the market study is 2020, the forecast period is from 2021 to 2026.

Market Insights
The United States has undertaken myriad initiatives in the last decade, in order to promote the adoption and use of precision medicine. For instance, the Precision Medicine Initiative Cohort Program was created during the tenure of the country’s former president Barack Obama, in 2015, with $130 million in funding. The program essentially focused on making advances in tailoring medical care to the individual. Moreover, its key mission is to accelerate health as well as medical breakthroughs, thereby propelling individualized care, treatment, and prevention. However, in 2016, the project was renamed, ’All of Us.’ Presently, the program is bilingual, with information and materials available in English and Spanish. Besides, additional languages are also expected to be added in the future.
Similarly, Sync for ScienceWeb Site Disclaimers (S4S), was launched in 2016. It entails a public-private collaboration to develop a secure, scalable, and simplified approach for patients to access and share their health data with scientific researchers, supporting the ’All of Us’ research program. As a result, these factors are anticipated to fuel the precision medicine market growth in the United States, during the forecast period.

Competitive Insights
Some of the distinguished companies operating in the market are, Pfizer Inc, Abbott Laboratories, Novartis AG, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments